National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

recombinant tyrosinase-related protein-2
A recombinant therapeutic agent which is chemically identical to or similar to an endogenous non-mutated melanocyte differentiation antigen expressed by both normal and malignant melanocytes. Vaccinations with recombinant tyrosinase-related protein-2 may elicit an antitumoral cytotoxic T-cell response against tumor cells and some normal cells that express tyrosinase-related protein-2. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonym:Tyrosinase-Related Protein-2
Abbreviation:TRP-2



Previous:recombinant thyrotropin alfa, recombinant tissue plasminogen activator, recombinant TNF-related apoptosis-inducing ligand, recombinant transforming growth factor-beta-2, recombinant tumor necrosis factor family protein
Next:recombinant vaccinia prostate-specific antigen vaccine, recombinant vaccinia-B7.1 vaccine, recombinant vaccinia-CEA(6D)-TRICOM vaccine, recombinant vaccinia-MUC-1 vaccine, recombinant vaccinia-multiepitope melanoma peptides-B7.1-B7.2 vaccine

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov